Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Fluvoxamine plus standard care vs placebo + standard care

All‐cause mortality (at day 28) · symptomatic people with COVID‐19

Fluvoxamine plus standard care showed no clear difference in all‐cause mortality (at day 28) compared with placebo plus standard care (low certainty).

1 finding from 1 review

Fluvoxamine for the treatment of COVID‐19 2022 · Cochrane Headline outcomes only
RR 0.69 [0.38, 1.27]
2 studies · 1649 participants
Low